{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T01:42:59Z","timestamp":1779154979244,"version":"3.51.4"},"reference-count":34,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2009,7,29]],"date-time":"2009-07-29T00:00:00Z","timestamp":1248825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2009,8]]},"abstract":"<jats:p><jats:bold>Background and purpose:\u2002<\/jats:bold> The studies described here are the first to evaluate the <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> properties of <jats:sup>111<\/jats:sup>In\u2010CHX\u2010A\u2033\u2010panitumumab for radioimmunotherapy (\u03b1\u2010 and \u03b2<jats:sup>\u2010<\/jats:sup>\u2010emitters) and radioimmunoimaging (single photon emission computed tomography and positron emission tomography).<\/jats:p><jats:p><jats:bold>Experimental approach:\u2002<\/jats:bold> Twenty\u2010seven human carcinoma cell lines were analysed for expression of epidermal growth factor receptors by flow cytometry. Panitumumab was conjugated with CHX\u2010A\u2033\u2010DTPA (diethylenetriamine\u2010pentaacetic acid) and radiolabelled with <jats:sup>111<\/jats:sup>In. Immunoreactivity of the CHX\u2010A\u2033\u2010DTPA\u2010panitumumab and <jats:sup>111<\/jats:sup>In\u2010CHX\u2010A\u2033\u2010DTPA\u2010panitumumab was evaluated by radioimmunoassays. Tumour targeting was determined <jats:italic>in vivo<\/jats:italic> by direct quantitation of tumour and normal tissues and by \u03b3\u2010scintigraphy.<\/jats:p><jats:p><jats:bold>Key results:\u2002<\/jats:bold> For 26 of 27 human tumour cell lines, 95% of the cells expressed epidermal growth factor receptors over a range of intensity. Immunoreactivity of panitumumab was retained after modification with CHX\u2010A\u2033\u2010DTPA. Radiolabelling of the immunoconjugate with <jats:sup>111<\/jats:sup>In was efficient with a specific activity of 19.5 \u00b1 8.9\u2003mCi\u00b7mg<jats:sup>\u22121<\/jats:sup> obtained. Immunoreactivity and specificity of binding of the <jats:sup>111<\/jats:sup>In\u2010panitumumab was shown with A431 cells. Tumour targeting by <jats:sup>111<\/jats:sup>In\u2010panitumumab was demonstrated in athymic mice bearing A431, HT\u201029, LS\u2010174T, SHAW or SKOV\u20103 s.c. xenografts with little uptake observed in normal tissues. The <jats:sup>111<\/jats:sup>In\u2010panitumumab was also evaluated in non\u2010tumour\u2010bearing mice. Pharmacokinetic studies compared the plasma retention time of the <jats:sup>111<\/jats:sup>In\u2010panitumumab in both non\u2010tumour\u2010bearing and A431 tumour\u2010bearing mice. Tumour targeting was also visualized by \u03b3\u2010scintigraphy.<\/jats:p><jats:p><jats:bold>Conclusions and implications:\u2002<\/jats:bold> Panitumumab can be efficiently radiolabelled with <jats:sup>111<\/jats:sup>In with high labelling yields. Based on the efficiency in tumour targeting and low normal tissue uptake, panitumumab may be an effective targeting component for radioimmunodiagnostic and radioimmunotherapeutic applications.<\/jats:p>","DOI":"10.1111\/j.1476-5381.2009.00327.x","type":"journal-article","created":{"date-parts":[[2009,7,29]],"date-time":"2009-07-29T17:25:35Z","timestamp":1248888335000},"page":"1541-1548","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Preclinical evaluation of a monoclonal antibody targeting the epidermal growth factor receptor as a radioimmunodiagnostic and radioimmunotherapeutic agent"],"prefix":"10.1111","volume":"157","author":[{"given":"GL","family":"Ray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KE","family":"Baidoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KJ","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Garmestani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MW","family":"Brechbiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DE","family":"Milenic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,7,29]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.7-suppl_4-2"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.11.890"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1021\/mp800022a"},{"key":"e_1_2_8_5_1","first-page":"1022","article-title":"Radioimmunoscintigraphy of colon cancer with iodine\u2010131\u2010labeled B72.3 monoclonal antibody","volume":"29","author":"Carrasquillo JA","year":"1988","journal-title":"J Nucl Med"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0b013e32800feecb"},{"key":"e_1_2_8_7_1","first-page":"4597","article-title":"Radioimmunolocalization of human carcinoma xenografts with B72.3 second generation monoclonal antibodies","volume":"48","author":"Colcher D","year":"1988","journal-title":"Cancer Res"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa033025"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(78)91322-0"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0969-8051(02)00322-0"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.12-5-577"},{"key":"e_1_2_8_12_1","first-page":"653","article-title":"Recombinant human leukocyte interferon induces alterations in the antigen phenotype of human breast carcinoma cells","volume":"6","author":"Greiner JW","year":"1986","journal-title":"Anticancer Res"},{"key":"e_1_2_8_13_1","first-page":"6248","article-title":"Regulation of carcinoembryonic antigen expression in different human colorectal tumor cells by interferon\u2010gamma","volume":"50","author":"Guadagni F","year":"1990","journal-title":"Cancer Res"},{"key":"e_1_2_8_14_1","first-page":"833","article-title":"Influence of spatial configuration of carcinoma cell populations on the expression of a tumor\u2010associated glycoprotein","volume":"45","author":"Horan Hand P","year":"1985","journal-title":"Cancer Res"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-5890(99)00094-2"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa071834"},{"key":"e_1_2_8_17_1","first-page":"457","article-title":"Yttrium\u201090\u2010labeled anti\u2010CD20 monoclonal antibody therapy of recurrent B\u2010cell lymphoma","volume":"2","author":"Knox SJ","year":"1996","journal-title":"Clin Cancer Res"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2006.04.003"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0065"},{"key":"e_1_2_8_21_1","first-page":"6363","article-title":"Construction, binding properties, metabolism, and tumor targeting of a single\u2010chain Fv derived from the pancarcinoma monoclonal antibody CC49","volume":"51","author":"Milenic DE","year":"1991","journal-title":"Cancer Res"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0969-8051(02)00294-9"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1413"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1089\/108497804323071904"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2005.20.557"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2008.0493"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1021\/bc00016a014"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.2174\/1874471010902010009"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/1040-8428(94)00144-I"},{"key":"e_1_2_8_30_1","first-page":"163","article-title":"Therapeutic efficacy of a high\u2010affinity anticarcinoembryonic antigen monoclonal antibody (COL\u20101)","volume":"4","author":"Siler K","year":"1993","journal-title":"Biotechnol Ther"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.6.1316"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1357-2725(99)00015-1"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-0896(97)00130-2"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm070657w"},{"key":"e_1_2_8_35_1","first-page":"1236","article-title":"Eradication of established tumors by a fully human monoclonal antibody to the epidermal growth factor receptor without concomitant chemotherapy","volume":"59","author":"Yang XD","year":"1999","journal-title":"Cancer Res"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.2009.00327.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.2009.00327.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T01:17:45Z","timestamp":1697419065000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.2009.00327.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,29]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["10.1111\/j.1476-5381.2009.00327.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00327.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,29]]},"assertion":[{"value":"2009-07-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}